Annual EBIT
-$258.37 M
-$3.18 M-1.25%
31 December 2023
Summary:
Ionis Pharmaceuticals annual earnings before interest & taxes is currently -$258.37 million, with the most recent change of -$3.18 million (-1.25%) on 31 December 2023. During the last 3 years, it has fallen by -$130.02 million (-101.30%). IONS annual EBIT is now -173.57% below its all-time high of $367.20 million.IONS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$122.87 M
-$79.45 M-183.01%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly earnings before interest & taxes is currently -$122.87 million, with the most recent change of -$79.45 million (-183.01%) on 30 September 2024. Over the past year, it has dropped by -$2.44 million (-2.03%). IONS quarterly EBIT is now -154.43% below its all-time high of $225.72 million, reached on 31 December 2021.IONS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$270.37 M
-$2.44 M-0.91%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM earnings before interest & taxes is currently -$270.37 million, with the most recent change of -$2.44 million (-0.91%) on 30 September 2024. Over the past year, it has increased by +$48.61 million (+15.24%). IONS TTM EBIT is now -176.98% below its all-time high of $351.21 million, reached on 31 December 2019.IONS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | -2.0% | +15.2% |
| 3 y3 years | -101.3% | -48.3% | -1.6% |
| 5 y5 years | -723.7% | -891.7% | -262.7% |
IONS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -944.0% | at low | -154.4% | at low | -1966.8% | +15.2% |
| 5 y | 5 years | -173.6% | at low | -154.4% | at low | -177.0% | +15.2% |
| alltime | all time | -173.6% | at low | -154.4% | at low | -177.0% | +15.2% |
Ionis Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$122.87 M(+183.0%) | -$270.37 M(+0.9%) |
| June 2024 | - | -$43.41 M(-64.5%) | -$267.93 M(-5.0%) |
| Mar 2024 | - | -$122.17 M(-775.6%) | -$282.02 M(+9.7%) |
| Dec 2023 | -$258.37 M(+1.2%) | $18.08 M(-115.0%) | -$256.97 M(-19.4%) |
| Sept 2023 | - | -$120.43 M(+109.4%) | -$318.98 M(+30.5%) |
| June 2023 | - | -$57.50 M(-40.8%) | -$244.46 M(-15.4%) |
| Mar 2023 | - | -$97.12 M(+121.1%) | -$289.03 M(+13.3%) |
| Dec 2022 | -$255.19 M(+931.1%) | -$43.93 M(-4.3%) | -$255.16 M(-1861.8%) |
| Sept 2022 | - | -$45.91 M(-55.0%) | $14.48 M(-164.4%) |
| June 2022 | - | -$102.08 M(+61.4%) | -$22.48 M(<-9900.0%) |
| Mar 2022 | - | -$63.25 M(-128.0%) | $46.00 K(-100.2%) |
| Dec 2021 | -$24.75 M(-80.7%) | $225.72 M(-372.4%) | -$24.94 M(-90.6%) |
| Sept 2021 | - | -$82.87 M(+4.2%) | -$266.11 M(+25.3%) |
| June 2021 | - | -$79.55 M(-9.8%) | -$212.36 M(+28.0%) |
| Mar 2021 | - | -$88.24 M(+471.2%) | -$165.84 M(+28.5%) |
| Dec 2020 | -$128.35 M(-136.5%) | -$15.45 M(-47.0%) | -$129.06 M(-237.8%) |
| Sept 2020 | - | -$29.12 M(-11.8%) | $93.68 M(-32.3%) |
| June 2020 | - | -$33.03 M(-35.8%) | $138.32 M(-16.8%) |
| Mar 2020 | - | -$51.45 M(-124.8%) | $166.22 M(-52.7%) |
| Dec 2019 | $351.21 M(-1219.7%) | $207.29 M(+1235.7%) | $351.21 M(+111.4%) |
| Sept 2019 | - | $15.52 M(-402.1%) | $166.14 M(+17.0%) |
| June 2019 | - | -$5.14 M(-103.8%) | $141.99 M(+39.2%) |
| Mar 2019 | - | $133.53 M(+500.8%) | $102.02 M(-425.3%) |
| Dec 2018 | -$31.37 M(-212.1%) | $22.22 M(-357.5%) | -$31.36 M(-47.0%) |
| Sept 2018 | - | -$8.63 M(-80.9%) | -$59.13 M(+28.0%) |
| June 2018 | - | -$45.10 M(<-9900.0%) | -$46.21 M(-692.1%) |
| Mar 2018 | - | $141.00 K(-102.5%) | $7.80 M(-72.1%) |
| Dec 2017 | $27.99 M(-249.9%) | -$5.54 M(-229.2%) | $27.99 M(-71.6%) |
| Sept 2017 | - | $4.29 M(-51.8%) | $98.42 M(-11.5%) |
| June 2017 | - | $8.91 M(-56.1%) | $111.23 M(+102.8%) |
| Mar 2017 | - | $20.33 M(-68.7%) | $54.85 M(-393.8%) |
| Dec 2016 | -$18.67 M(-63.5%) | $64.89 M(+279.5%) | -$18.67 M(-87.1%) |
| Sept 2016 | - | $17.10 M(-136.0%) | -$145.27 M(-23.1%) |
| June 2016 | - | -$47.46 M(-10.8%) | -$188.91 M(+97.0%) |
| Mar 2016 | - | -$53.20 M(-13.8%) | -$95.88 M(+87.4%) |
| Dec 2015 | -$51.17 M(+59.0%) | -$61.71 M(+132.5%) | -$51.17 M(-252.8%) |
| Sept 2015 | - | -$26.54 M(-158.3%) | $33.49 M(-15.8%) |
| June 2015 | - | $45.56 M(-637.0%) | $39.75 M(-429.8%) |
| Mar 2015 | - | -$8.48 M(-137.0%) | -$12.05 M(-62.5%) |
| Dec 2014 | -$32.18 M(-31.8%) | $22.95 M(-213.2%) | -$32.18 M(-56.5%) |
| Sept 2014 | - | -$20.28 M(+225.1%) | -$74.00 M(-5.9%) |
| June 2014 | - | -$6.24 M(-78.2%) | -$78.62 M(-0.3%) |
| Mar 2014 | - | -$28.61 M(+51.6%) | -$78.88 M(+67.1%) |
| Dec 2013 | -$47.20 M(-11.7%) | -$18.87 M(-24.2%) | -$47.20 M(+36.6%) |
| Sept 2013 | - | -$24.90 M(+283.1%) | -$34.56 M(-17.9%) |
| June 2013 | - | -$6.50 M(-312.5%) | -$42.07 M(+33.3%) |
| Mar 2013 | - | $3.06 M(-149.1%) | -$31.56 M(-40.9%) |
| Dec 2012 | -$53.44 M(-21.5%) | -$6.22 M(-80.8%) | -$53.44 M(-14.0%) |
| Sept 2012 | - | -$32.41 M(-907.8%) | -$62.14 M(+19.9%) |
| June 2012 | - | $4.01 M(-121.3%) | -$51.84 M(-26.3%) |
| Mar 2012 | - | -$18.81 M(+26.0%) | -$70.29 M(+3.3%) |
| Dec 2011 | -$68.06 M(+42.0%) | -$14.93 M(-32.5%) | -$68.06 M(+7.0%) |
| Sept 2011 | - | -$22.11 M(+53.1%) | -$63.63 M(+25.7%) |
| June 2011 | - | -$14.44 M(-12.9%) | -$50.63 M(-12.8%) |
| Mar 2011 | - | -$16.58 M(+57.9%) | -$58.08 M(+21.2%) |
| Dec 2010 | -$47.93 M(+151.0%) | -$10.50 M(+15.2%) | -$47.93 M(-1.6%) |
| Sept 2010 | - | -$9.12 M(-58.4%) | -$48.69 M(+0.6%) |
| June 2010 | - | -$21.89 M(+240.9%) | -$48.42 M(+78.9%) |
| Mar 2010 | - | -$6.42 M(-43.0%) | -$27.06 M(+41.7%) |
| Dec 2009 | -$19.09 M(+605.3%) | -$11.26 M(+27.4%) | -$19.09 M(+33.0%) |
| Sept 2009 | - | -$8.84 M(+1546.7%) | -$14.36 M(+667.8%) |
| June 2009 | - | -$537.00 K(-134.6%) | -$1.87 M(-191.2%) |
| Mar 2009 | - | $1.55 M(-123.7%) | $2.05 M(-175.8%) |
| Dec 2008 | -$2.71 M(-91.8%) | -$6.53 M(-279.1%) | -$2.71 M(-292.3%) |
| Sept 2008 | - | $3.64 M(+7.7%) | $1.41 M(-82.0%) |
| June 2008 | - | $3.38 M(-205.5%) | $7.82 M(-151.4%) |
| Mar 2008 | - | -$3.21 M(+32.8%) | -$15.22 M(-53.8%) |
| Dec 2007 | -$32.92 M | -$2.41 M(-124.0%) | -$32.92 M(-25.9%) |
| Sept 2007 | - | $10.06 M(-151.2%) | -$44.42 M(-39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$19.66 M(-5.9%) | -$73.02 M(+3.3%) |
| Mar 2007 | - | -$20.90 M(+50.2%) | -$70.68 M(+7.5%) |
| Dec 2006 | -$65.75 M(+30.9%) | -$13.91 M(-25.0%) | -$65.75 M(+8.0%) |
| Sept 2006 | - | -$18.54 M(+7.1%) | -$60.87 M(+11.0%) |
| June 2006 | - | -$17.32 M(+8.4%) | -$54.82 M(+10.1%) |
| Mar 2006 | - | -$15.98 M(+76.9%) | -$49.78 M(-0.9%) |
| Dec 2005 | -$50.22 M(-41.2%) | -$9.03 M(-27.7%) | -$50.22 M(-17.1%) |
| Sept 2005 | - | -$12.49 M(+1.8%) | -$60.56 M(-14.0%) |
| June 2005 | - | -$12.27 M(-25.3%) | -$70.45 M(-11.4%) |
| Mar 2005 | - | -$16.42 M(-15.2%) | -$79.51 M(-6.9%) |
| Dec 2004 | -$85.43 M(+10.7%) | -$19.37 M(-13.4%) | -$85.43 M(-2.4%) |
| Sept 2004 | - | -$22.38 M(+4.9%) | -$87.53 M(+3.9%) |
| June 2004 | - | -$21.34 M(-4.5%) | -$84.22 M(+4.5%) |
| Mar 2004 | - | -$22.34 M(+4.0%) | -$80.60 M(+4.4%) |
| Dec 2003 | -$77.17 M(+56.1%) | -$21.48 M(+12.7%) | -$77.18 M(+17.7%) |
| Sept 2003 | - | -$19.07 M(+7.6%) | -$65.57 M(+2.4%) |
| June 2003 | - | -$17.72 M(-6.3%) | -$64.01 M(+9.2%) |
| Mar 2003 | - | -$18.91 M(+91.6%) | -$58.63 M(+18.6%) |
| Dec 2002 | -$49.44 M(+7.2%) | -$9.87 M(-43.6%) | -$49.44 M(+4.6%) |
| Sept 2002 | - | -$17.51 M(+41.9%) | -$47.26 M(+37.1%) |
| June 2002 | - | -$12.34 M(+27.0%) | -$34.46 M(-10.7%) |
| Mar 2002 | - | -$9.72 M(+26.3%) | -$38.59 M(-16.3%) |
| Dec 2001 | -$46.10 M(+59.0%) | -$7.70 M(+63.5%) | -$46.10 M(-4.8%) |
| Sept 2001 | - | -$4.71 M(-71.4%) | -$48.42 M(+11.3%) |
| June 2001 | - | -$16.46 M(-4.5%) | -$43.50 M(+23.5%) |
| Mar 2001 | - | -$17.23 M(+72.1%) | -$35.22 M(+21.5%) |
| Dec 2000 | -$28.99 M(-32.7%) | -$10.01 M(-4960.2%) | -$28.99 M(-7.9%) |
| Sept 2000 | - | $206.00 K(-102.5%) | -$31.48 M(-20.9%) |
| June 2000 | - | -$8.18 M(-25.7%) | -$39.78 M(-8.8%) |
| Mar 2000 | - | -$11.01 M(-11.9%) | -$43.61 M(+1.2%) |
| Dec 1999 | -$43.10 M(+32.6%) | -$12.50 M(+54.3%) | -$43.10 M(+6.9%) |
| Sept 1999 | - | -$8.10 M(-32.5%) | -$40.30 M(+29.6%) |
| June 1999 | - | -$12.00 M(+14.3%) | -$31.10 M(-3.1%) |
| Mar 1999 | - | -$10.50 M(+8.2%) | -$32.10 M(-1.5%) |
| Dec 1998 | -$32.50 M(+3.8%) | -$9.70 M(-981.8%) | -$32.60 M(-1.8%) |
| Sept 1998 | - | $1.10 M(-108.5%) | -$33.20 M(-10.0%) |
| June 1998 | - | -$13.00 M(+18.2%) | -$36.90 M(+9.8%) |
| Mar 1998 | - | -$11.00 M(+6.8%) | -$33.60 M(+6.7%) |
| Dec 1997 | -$31.30 M(+7.6%) | -$10.30 M(+296.2%) | -$31.50 M(+2.6%) |
| Sept 1997 | - | -$2.60 M(-73.2%) | -$30.70 M(-11.8%) |
| June 1997 | - | -$9.70 M(+9.0%) | -$34.80 M(+4.8%) |
| Mar 1997 | - | -$8.90 M(-6.3%) | -$33.20 M(+14.1%) |
| Dec 1996 | -$29.10 M(+13.7%) | -$9.50 M(+41.8%) | -$29.10 M(+12.8%) |
| Sept 1996 | - | -$6.70 M(-17.3%) | -$25.80 M(-2.6%) |
| June 1996 | - | -$8.10 M(+68.8%) | -$26.50 M(+8.6%) |
| Mar 1996 | - | -$4.80 M(-22.6%) | -$24.40 M(-5.1%) |
| Dec 1995 | -$25.60 M(+13.8%) | -$6.20 M(-16.2%) | -$25.70 M(-16.3%) |
| Sept 1995 | - | -$7.40 M(+23.3%) | -$30.70 M(+8.5%) |
| June 1995 | - | -$6.00 M(-1.6%) | -$28.30 M(+4.4%) |
| Mar 1995 | - | -$6.10 M(-45.5%) | -$27.10 M(+6.3%) |
| Dec 1994 | -$22.50 M(+23.0%) | -$11.20 M(+124.0%) | -$25.50 M(+36.4%) |
| Sept 1994 | - | -$5.00 M(+4.2%) | -$18.70 M(+3.3%) |
| June 1994 | - | -$4.80 M(+6.7%) | -$18.10 M(+1.1%) |
| Mar 1994 | - | -$4.50 M(+2.3%) | -$17.90 M(-3.2%) |
| Dec 1993 | -$18.30 M(-15.3%) | -$4.40 M(0.0%) | -$18.50 M(-14.0%) |
| Sept 1993 | - | -$4.40 M(-4.3%) | -$21.50 M(-2.3%) |
| June 1993 | - | -$4.60 M(-9.8%) | -$22.00 M(+1.9%) |
| Mar 1993 | - | -$5.10 M(-31.1%) | -$21.60 M(+0.5%) |
| Dec 1992 | -$21.60 M(+105.7%) | -$7.40 M(+51.0%) | -$21.50 M(+12.6%) |
| Sept 1992 | - | -$4.90 M(+16.7%) | -$19.10 M(+15.1%) |
| June 1992 | - | -$4.20 M(-16.0%) | -$16.60 M(+12.9%) |
| Mar 1992 | - | -$5.00 M(0.0%) | -$14.70 M(+33.6%) |
| Dec 1991 | -$10.50 M(+133.3%) | -$5.00 M(+108.3%) | -$11.00 M(-8.3%) |
| Sept 1991 | - | -$2.40 M(+4.3%) | -$12.00 M(+31.9%) |
| June 1991 | - | -$2.30 M(+76.9%) | -$9.10 M(+44.4%) |
| Mar 1991 | - | -$1.30 M(-78.3%) | -$6.30 M(+40.0%) |
| Dec 1990 | -$4.50 M | -$6.00 M(-1300.0%) | -$4.50 M(-400.0%) |
| Sept 1990 | - | $500.00 K(0.0%) | $1.50 M(+50.0%) |
| June 1990 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Mar 1990 | - | $500.00 K | $500.00 K |
FAQ
- What is Ionis Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual EBIT year-on-year change?
- What is Ionis Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly EBIT year-on-year change?
- What is Ionis Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM EBIT year-on-year change?
What is Ionis Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of IONS is -$258.37 M
What is the all time high annual EBIT for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual earnings before interest & taxes is $367.20 M
What is Ionis Pharmaceuticals annual EBIT year-on-year change?
Over the past year, IONS annual earnings before interest & taxes has changed by -$3.18 M (-1.25%)
What is Ionis Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of IONS is -$122.87 M
What is the all time high quarterly EBIT for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly earnings before interest & taxes is $225.72 M
What is Ionis Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, IONS quarterly earnings before interest & taxes has changed by -$2.44 M (-2.03%)
What is Ionis Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of IONS is -$270.37 M
What is the all time high TTM EBIT for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM earnings before interest & taxes is $351.21 M
What is Ionis Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, IONS TTM earnings before interest & taxes has changed by +$48.61 M (+15.24%)